Bramley
TL2 Member · Trento, IT
Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.
Joined 12 May 2025 · last posted 10d
97 posts, newest first. Showing up to 150.
-
What I would want from a home test that does not exist yet — what changed since Replied, post #99 · Analytics › Home & field testing · 18 Jul 2026 · 11 likes Post #95 describes the usual case. This is about the unusual one. Photographs of test results posted here are worth including with the lighting and the timing stated,…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #36 · Practice › Interactions · 17 Jul 2026 · 7 likes Oral medications with a narrow therapeutic index are the ones where that matters most. The interaction is about rate and timing rather than about the total absorbed, in…
-
Common supplements people ask about, assessed one at a time Replied, post #50 · Practice › Interactions · 15 Jul 2026 · 10 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Asking a follow-up: new topic or new reply? Replied, post #50 · Start Here › How to Ask · 12 Jul 2026 · 1 like Post #46 describes the usual case. This is about the unusual one. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
Micro-titration: a disputed topic, argued properly Replied, post #103 · Practice › Dosing & titration · 11 Jul 2026 · 0 likes I would put moderate confidence on the mainstream reading of micro-titration and no more. That is not scepticism for its own sake; it is where the sourcing actually…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #26 · Clinical › Comorbidities · 11 Jul 2026 · 10 likes Where I part company with post #22, and it is a narrow parting. On Osteoarthritis and mechanical versus metabolic, the part that usually goes wrong is that the question…
-
Journal club: LEADER as the historical anchor Replied, post #101 · Evidence › Journal club · 8 Jul 2026 · 0 likes I have three months of notes on LEADER and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite conclusion…
-
Follow-up: UK access routes, dated and sourced Replied, post #10 · marked as the solution · Regional › UK & Ireland · 8 Jul 2026 · 8 likes Where the compound is supplied with a device, the device and the compound have separate availability positions and the device is more often the constraint. I am aware…
-
How shortages have affected compounding permissions Replied, post #21 · Access › Shortages · 7 Jul 2026 · 7 likes Worth separating two things that post #17 runs together. Shortages is a good example of a question where the honest answer is boring and the interesting answers are…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #25 · Compounds › Retatrutide · 6 Jul 2026 · 29 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #52 · Clinical › Bloodwork · 4 Jul 2026 · 8 likes What I would check first on Liver enzymes drifting is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Programming during a large energy deficit Replied, post #31 · Nutrition & Training › Resistance training · 3 Jul 2026 · 0 likes Strength and hypertrophy respond to different things, and preserving one during a deficit is a different objective from building the other.
-
Revisiting: Body image changing more slowly than the body Replied, post #8 · Wellbeing › Mental health · 1 Jul 2026 · 6 likes Worth separating two things that post #6 runs together. A request rather than an answer: could whoever has the primary source for Body image post it? I have seen the…
-
Revisiting: The best-written scientific paper you have read Replied, post #64 · Lounge › Off topic · 1 Jul 2026 · 6 likes Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic. None of…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #60 · Analytics › Home & field testing · 28 Jun 2026 · 12 likes Coming back to post #58, because the follow-up matters more than the original answer. The most useful home practice is not a test at all: photograph the vial, the cake,…
-
Racemisation and why it is invisible to a mass measurement Replied, post #99 · Analytics › Impurities & related substances · 14 Jun 2026 · 22 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #42 · Analytics › HPLC & UHPLC · 13 Jun 2026 · 14 likes Injection volume matters because column overload distorts peak shape, and an overloaded main peak can swallow a small neighbour. A certificate without injection volume…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #18 · Start Here › Welcome · 12 Jun 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #9 · Analytics › HPLC & UHPLC · 6 Jun 2026 · 2 likes Adding the boring version of Carryover, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations, in…
-
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #18 · Start Here › Welcome · 3 Jun 2026 · 0 likes Muting is under-used here. A category you mute stops appearing in Latest for you, and you can unmute it in a second. Most long-term members read four or five categories…
-
Why this subcategory is stricter about sourcing than most Replied, post #37 · Compounds › Secretagogues & GH axis · 1 Jun 2026 · 14 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
-
Citation sweep results: how many references did not say what was claimed Replied, post #101 · Meta › Wiki maintenance · 24 May 2026 · 6 likes Post #100 and I disagree about the size of the effect, not about the direction. If you are new and reading this thread for the answer to citation sweep results: the…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #20 · Compounds › Oral incretins · 14 May 2026 · 24 likes Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is made, stored and analysed. Comparing it to oral semaglutide as…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #44 · Practice › Reconstitution · 13 May 2026 · 5 likes Post #43 is right about the mechanism and I think understates the practical bit. The best check on any reconstitution calculation is to do it twice by two different…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #16 · Compounds › Oral incretins · 12 May 2026 · 4 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
[2026 update] Why 99.2% and 97.8% on the same lot can both be correct Started this topic · Analytics › HPLC & UHPLC · 30 Apr 2026 · 13 likes Why 99.2% and 97.8% on the same lot can both be correct — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to…
-
Does a peptide degrade silently, with no visual change? Replied, post #15 · Practice › Storage & stability · 24 Apr 2026 · 2 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #48 · Sourcing › Logistics · 21 Apr 2026 · 25 likes The most useful reply I ever got about Regional warehouse stock versus direct was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #38 · Evidence › Trials · 9 Apr 2026 · 14 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Choosing which test to pay for, given a fixed budget Replied, post #56 · Sourcing › Independent verification · 6 Apr 2026 · 19 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. If that reads as pedantic, it is, and it…
-
Grapefruit: why this class is not the class that cares Replied, post #68 · Practice › Interactions · 22 Mar 2026 · 27 likes Delayed gastric emptying is the mechanism behind most of the plausible interactions in this class: anything whose absorption depends on how quickly the stomach empties…
-
Search filters: what is missing Replied, post #37 · Meta › Site feedback · 18 Mar 2026 · 25 likes Marking my place. If it changes for me I will come back and say so.
-
Revisiting: Maintainer handover: how it works Replied, post #38 · Meta › Wiki maintenance · 8 Mar 2026 · 8 likes I had written a reply contradicting post #35 and deleted it. Here is what survived. The failure mode on Maintainer handover is boring rather than dramatic. It is almost…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #38 · Research Methods › N-of-1 designs · 2 Mar 2026 · 0 likes Narrowing post #35, because the general version has more than one answer. Pre-registering a personal experiment has been discussed here with more heat than it deserves,…
-
Grapefruit: why this class is not the class that cares Replied, post #6 · Practice › Interactions · 2 Mar 2026 · 16 likes Picking up post #5: that is the part I would want checked first. The useful distinction on grapefruit is between what was measured and what was inferred from it. Both…
-
Bioimpedance and hydration: why the number moves Replied, post #13 · Outcomes › Body composition · 2 Mar 2026 · 9 likes The most useful protocol is the one you will actually repeat identically. An imperfect measurement repeated consistently beats a better one repeated carelessly. Take it…
-
Forced degradation studies: designing one that is informative Replied, post #13 · Analytics › Method validation · 1 Mar 2026 · 10 likes I read post #9 twice before replying, because I had assumed the opposite. Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of…
-
Moderation log format change Replied, post #30 · Meta › Announcements · 19 Feb 2026 · 0 likes I read post #28 twice before replying, because I had assumed the opposite. The edit is clearer. For anyone arriving now, read the edited version — the confusion in the…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #24 · Outcomes › Body composition · 7 Feb 2026 · 2 likes Where I part company with post #22, and it is a narrow parting. Comparison to published data: the trials reported mean fat and lean mass changes. Individual results…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #53 · Documentation › Wiki requests · 24 Jan 2026 · 14 likes Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion with specific content you think should be added.
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #53 · Start Here › How to Ask · 16 Jan 2026 · 33 likes Do not apologise in the first line. It costs you the space where the question should be, and nobody here thinks a question is an imposition.
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #21 · Data & Tools › Calculators · 12 Jan 2026 · 0 likes Narrowing post #20, because the general version has more than one answer. A saved calculation is worth more than a remembered one. Write down the inputs alongside the…
-
Reading an interaction checker output critically Replied, post #90 · Practice › Interactions · 12 Jan 2026 · 8 likes Absence of an interaction study is not evidence of no interaction. A great many combinations discussed here have simply never been studied, and saying so is more useful…
-
A partial dose because the pen emptied mid-injection Replied, post #103 · Practice › Administration · 10 Jan 2026 · 0 likes Confirming post #100 from a second method, which matters more than confirming it from a second person. A genuinely late dose: the labelling generally says that if the…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #29 · Practice › Interactions · 6 Jan 2026 · 0 likes Post #28 is right about the mechanism and I think understates the practical bit. Where I have landed on Metformin co-administration, having got it wrong once in public:…
-
Amylin receptor signalling and satiety — what changed since Replied, post #4 · Pharmacology › Receptor biology · 13 Dec 2025 · 8 likes On the opening post — agreed on the reasoning, with one qualification. Long-term receptor changes: very little is known about what happens to receptor expression,…
-
Prescription requirements and telehealth models Replied, post #61 · Sourcing › Regulatory · 11 Dec 2025 · 0 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category. Posted…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #77 · Analytics › COA interpretation · 25 Nov 2025 · 1 like The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #63 · Compounds › Oral incretins · 19 Nov 2025 · 17 likes Coming back to post #59, because the follow-up matters more than the original answer. Why administration conditions matter for oral semaglutide and not for injectables:…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #117 · Practice › Storage & stability · 2 Nov 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. That holds for…
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #2 · Practice › Side effects · 10 Oct 2025 · 21 likes Thank you for taking the time. That was more work than a reply usually is.
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 30 Sep 2025 · 15 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #58 · Practice › Dosing & titration · 16 Sep 2025 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #123 · Evidence › Study critique · 16 Sep 2025 · 3 likes Bookmarking this. I will come back when I have something worth adding.
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #76 · Devices › Cold chain · 13 Sep 2025 · 2 likes Do not judge cold-chain performance from a single delivery in either direction. It is a distribution and one sample from it is one sample. I checked the source rather…
-
Documentation that appears only after payment Replied, post #20 · Sourcing › Red flags · 8 Sep 2025 · 13 likes An honest declaration on documentation: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Guidelines revision: what changed and why — one year on Replied, post #13 · Meta › Announcements · 5 Sep 2025 · 14 likes Worth separating two things that post #11 runs together. Archives: older announcements are archived by date. Checking archives is useful if you want to know what…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #25 · Compounds › Tirzepatide · 28 Aug 2025 · 0 likes Post #21 describes the usual case. This is about the unusual one. Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading…
-
Asking about a compound your prescriber has not heard of Replied, post #134 · Clinical › Prescriber conversations · 22 Aug 2025 · 0 likes Where you disagree, saying so plainly and asking for the reasoning is better than agreeing and not following the plan.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #84 · Evidence › Journal club · 22 Aug 2025 · 3 likes Coming back to post #82, because the follow-up matters more than the original answer. The baseline characteristics table is the single most useful page for the…
-
Hypertension improvement and when medication needs revisiting Replied, post #10 · Clinical › Comorbidities · 15 Aug 2025 · 21 likes Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable. If anyone can…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #18 · Compounds › Secretagogues & GH axis · 5 Aug 2025 · 33 likes The strongest argument against my own position on IGF-1, stated as well as I can state it, since nobody else has yet.
-
How to research a compound with no human data without deceiving yourself Replied, post #37 · Compounds › Other compounds · 1 Aug 2025 · 6 likes I changed my mind about research a compound after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
-
Immortal time bias in a claims-database study Replied, post #8 · Evidence › Study critique · 28 Jul 2025 · 0 likes Reporting bias within a paper — a result in a figure that is absent from the abstract — is checkable and is worth checking when the claim matters. That is the version I…
-
A preprint whose numbers changed substantially at publication Replied, post #4 · Evidence › Preprints · 27 Jul 2025 · 5 likes Reading rather than answering, but this is the post I would point somebody at.
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #88 · Compounds › Semaglutide · 26 Jul 2025 · 3 likes Confirming post #87 from a second method, which matters more than confirming it from a second person. On alcohol: the labelling does not contraindicate it, but it…
-
Journal club: STEP 8 and the fairness of the comparator dose Replied, post #2 · Evidence › Journal club · 22 Jul 2025 · 0 likes Adding the measurement that the opening post says would settle it. The question underneath STEP 8 is usually "how would I tell?" rather than "what is true?", and that…
-
Why the timeline is on the right and not the left Replied, post #43 · Meta › Site feedback · 20 Jul 2025 · 17 likes This follows post #40 rather than contradicting it. Timeline is worth one more sentence than it usually gets, and the sentence is the one about how the number was…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #54 · Sourcing › Regulatory · 19 Jul 2025 · 0 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
Interpreting a composition change that is within the error bars Replied, post #14 · Outcomes › Body composition · 10 Jul 2025 · 0 likes Narrowing post #11, because the general version has more than one answer. Precision versus accuracy: the precision you need depends on what question you are answering.…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #29 · Access › Insurance & coverage · 29 Jun 2025 · 0 likes Post #27 answers the question as asked. The question underneath it is different. Where I have landed on Reading a denial letter, having got it wrong once in public: the…
-
Why plausible mechanism is not evidence of effect Replied, post #17 · Compounds › Repair & healing peptides · 23 Jun 2025 · 0 likes The arithmetic on plausible mechanism is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
Half-life, steady state, and accumulation worked through Replied, post #81 · Pharmacology › Pharmacokinetics · 7 Jun 2025 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Half-life, steady state, and accumulation worked through Replied, post #64 · Pharmacology › Pharmacokinetics · 4 Jun 2025 · 18 likes I read the earlier replies on half-life twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather…
-
A well-designed study with a badly written abstract Replied, post #83 · Evidence › Study critique · 15 May 2025 · 22 likes I came in to disagree and I am leaving without a disagreement.
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #12 · Compounds › Repair & healing peptides · 11 May 2025 · 10 likes The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide, which is one of the few things about it that is well…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #49 · Data & Tools › Calculators · 4 May 2025 · 2 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
A supplier that answers analytical questions with restated claims Replied, post #52 · Sourcing › Red flags · 6 Apr 2025 · 0 likes I have three months of notes on supplier and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite conclusion…
-
A certificate with no method stated: what can you conclude? Replied, post #15 · Analytics › COA interpretation · 1 Apr 2025 · 3 likes Post #14 answers the question as asked. The question underneath it is different. The fields that make one usable: lot identifier matching the container, test date,…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #13 · Compounds › Semaglutide · 16 Feb 2025 · 4 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Protein density versus volume when you cannot eat much Replied, post #3 · Nutrition & Training › Protein & intake · 21 Jan 2025 · 1 like The mechanism is not mysterious. Substantial energy restriction with inadequate protein and no resistance stimulus loses lean tissue as well as fat. Reporting the…
-
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #11 · Compounds › Secretagogues & GH axis · 18 Jan 2025 · 20 likes Taking GHRH analogues versus ghrelin mimetics seriously for a moment rather than deflecting: the honest position is that the community has observations and no…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #57 · Sourcing › Regulatory · 4 Jan 2025 · 2 likes Research-use-only labelling is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #124 · Compounds › Oral incretins · 28 Dec 2024 · 5 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…
-
[2026 update] New subcategory: rationale and scope Replied, post #34 · Meta › Announcements · 1 Dec 2024 · 13 likes Practical note on New subcategory: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #30 · Nutrition & Training › Protein & intake · 30 Nov 2024 · 7 likes Reading this Meeting a protein target thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Washout with a one-week half-life: the arithmetic Replied, post #8 · Research Methods › N-of-1 designs · 23 Nov 2024 · 0 likes What I would want before treating washout as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #26 · Practice › Interactions · 13 Nov 2024 · 5 likes I read post #25 twice before replying, because I had assumed the opposite. A pharmacist can answer most questions in this subcategory in a few minutes with access to a…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #60 · Devices › Syringes & needles · 4 Nov 2024 · 0 likes Filter needles are for drawing from glass ampoules where particulate is a real risk. For a stoppered vial they add dead volume in exchange for very little.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #96 · Analytics › COA interpretation · 26 Oct 2024 · 0 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #57 · Analytics › Method validation · 23 Oct 2024 · 0 likes An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods'…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #5 · Compounds › Oral incretins · 11 Oct 2024 · 11 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #63 · Clinical › Bloodwork · 28 Sep 2024 · 4 likes Answering the question post #59 raises rather than the one it answers. What I would want before treating bring a laboratory as settled: the method, the sample, and…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #42 · Compounds › Retatrutide · 17 Sep 2024 · 22 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Blind submission and why it changes minds Replied, post #58 · Sourcing › Independent verification · 11 Sep 2024 · 13 likes I had written a reply contradicting post #54 and deleted it. Here is what survived. Blind submission is worth one more sentence than it usually gets, and the sentence…
-
How to ask for a dose change without antagonising anyone Replied, post #12 · Clinical › Prescriber conversations · 6 Aug 2024 · 0 likes Everything in post #10 holds. The case it does not cover is the one I have. Clarifying indication: if a compound is approved for diabetes but you have obesity without…
-
How this community labels and discusses unrefereed work Replied, post #80 · Evidence › Preprints · 13 Jul 2024 · 6 likes The arithmetic in post #79 is right; the assumption feeding it is the part to check. Unrefereed work is not worthless. A great deal of it survives review substantially…